Suchergebnisse - "Gai, Xiameng"

PubPharm (6)

1

Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer

enthalten in: Cancer research | 2024

von Gai, X. | Liu, Y. | Lan, X. | +16

2

Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Pu, C. | Li, Y. | Fu, Y. | +13

3

Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells

enthalten in: Advanced Science | 2024

von Pu, C. | Li, Y. | Fu, Y. | +13

4

A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma

enthalten in: Cell discovery | 2023

von Jiang, X. | Deng, W. | Tao, S. | +22

5

SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors

enthalten in: Cell research | 2022

von Wang, X. | Chen, Z. | Xu, J. | +33

6

A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies

enthalten in: Molecular cell | 2021

von Liu, Z. | Liu, Y. | Qian, L. | +12

1
[1]